Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2012
06/14/2012WO2012076663A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
06/14/2012WO2012076066A1 Anti-ror1 antibodies and uses thereof
06/14/2012WO2012075679A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
06/14/2012WO2012075581A1 Antibodies selective for cells presenting erbb2 at high density
06/14/2012WO2012048134A3 Methods for treating psoriasis
06/14/2012WO2012047706A9 Methods for promotiing reinnervation of auditory hair cells
06/14/2012WO2012033911A3 Polyionic papilloma virus-like particle (vlp) vaccines
06/14/2012WO2012027379A3 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
06/14/2012WO2012023051A9 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
06/14/2012WO2012021841A3 Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof
06/14/2012WO2012019188A3 Methods and compositions for the inhibition of fructokinase
06/14/2012WO2011140135A9 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
06/14/2012WO2011139385A3 Genetic signatures in hiv-1 subtype c envelope glycoproteins
06/14/2012WO2011056060A8 Recombinant matrix protein of nipah virus
06/14/2012WO2011050384A9 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
06/14/2012WO2011008939A3 Porous-wall hollow glass microspheres as carriers for biomolecules
06/14/2012WO2010096418A3 Antibody molecules having specificity for human ox40
06/14/2012US20120151612 Non-surgical approach to prevent and correct craniofacial malformations during development
06/14/2012US20120150087 Solid dressing for treating wounded tissue
06/14/2012US20120150023 Microneedle arrays for active agent delivery
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149102 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
06/14/2012US20120149095 Dna promoters and anthrax vaccines
06/14/2012US20120149089 Animal product free system and process for purifying a botulinum toxin
06/14/2012US20120149085 Fusion proteins containing recombinant cytotoxic rnases
06/14/2012US20120149044 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
06/14/2012US20120148676 Artificial cell constructs for cellular manipulation
06/14/2012US20120148674 Self-assembling hydrogels based on dicephalic peptide amphiphiles
06/14/2012US20120148666 Anti-rsv immunogens and methods of immunization
06/14/2012US20120148660 Conjugates of synthetic tlr agonists and uses therefor
06/14/2012US20120148659 Solid dressing for treating wounded tissue
06/14/2012US20120148658 Solid dressing for treating wounded tissue
06/14/2012US20120148656 Sheet-form preparation and method for producing the same
06/14/2012US20120148627 Compositions and Methods for Treatment of Neoplastic Disease
06/14/2012US20120148626 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148624 Mutants of cholesterol-dependent cytolysins and uses thereof
06/14/2012US20120148623 Vaccination for lawsonia intracellularis
06/14/2012US20120148622 Live Attenuated Influenza Virus Vaccines Comprising Microrna Response Elements
06/14/2012US20120148621 Methods and compositions for promoting a cell-mediated immune response
06/14/2012US20120148620 Compositions and methods for vaccinating cattle
06/14/2012US20120148619 Adjuvanting meningococcal factor h binding protein
06/14/2012US20120148618 Multiple variants of meningococcal protein nmb1870
06/14/2012US20120148617 Multiple variants of meningococcal protein nbm1870
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148615 Polypeptides from non-typeable haemophilus influenzae
06/14/2012US20120148614 Interaction of Moraxella Catarrhalis with Epithelial Cells, Extracellular Matrix Proteins and the Complement System
06/14/2012US20120148613 Multivalent entrain-and-amplify immunotherapeutics for carcinoma
06/14/2012US20120148612 Grass peptides for vaccine
06/14/2012US20120148611 Cyclophosphamide in Combination with Anti-Idiotypic Vaccines
06/14/2012US20120148610 Monomethylvaline compounds capable of conjugation to ligands
06/14/2012US20120148609 Intracoronary device and method of use thereof
06/14/2012US20120148608 Monomethylvaline compounds capable of conjugation to ligands
06/14/2012US20120148607 Anti c-met antibodies
06/14/2012US20120148606 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148605 Immunomodulatory Methods And Systems For Treatment And/Or Prevention Of Atherosclerosis And Related Proteins, Peptide And Compositions
06/14/2012US20120148604 Trp inhibitors and uses thereof
06/14/2012US20120148603 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
06/14/2012US20120148602 Cancer Treatment With Endothelin Receptor Antagonists
06/14/2012US20120148601 Bacterial superantigen vaccines
06/14/2012US20120148600 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use
06/14/2012US20120148599 Methods and compositions for neural disease immunotherapy
06/14/2012US20120148598 Methods for treating a tumor using an antibody that specifically binds grp94
06/14/2012US20120148597 Human monoclonal antibodies to ctla-4
06/14/2012US20120148596 Molecular conjugates comprising human monoclonal antibodies to dendritic cells
06/14/2012US20120148595 Gaba-linked anthracycline-lipid conjugates
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148593 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148592 Neutralizing anti-ccl20 antibodies
06/14/2012US20120148591 Antibodies That Bind Amyloid Oligomers
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148589 Human cancer-related gene, its encoded products and applications
06/14/2012US20120148588 Methods for increasing thermogenic adipocytes
06/14/2012US20120148587 Polypeptide formulation
06/14/2012US20120148586 Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
06/14/2012US20120148585 Fusion molecules and methods for treatment of immune diseases
06/14/2012US20120148584 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the threatment of early stage tumors
06/14/2012US20120148583 Cytokine antagonists for neurological and neuropsychiatric disorders
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148581 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes
06/14/2012US20120148580 Methods for identification of sites for igg conjugation
06/14/2012US20120148579 Antibodies to ox-2/cd200 and uses thereof
06/14/2012US20120148578 Methods and compositions for inhibiting cd32b expressing cells
06/14/2012US20120148577 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
06/14/2012US20120148576 Humanized anti-cd 19 antibody formulations
06/14/2012US20120148575 Methods Of Reducing Eosinophil Levels
06/14/2012US20120148574 Diagnostic Markers for Ankylosing Spondylitis
06/14/2012US20120148573 Compositions and methods for the diagnosis and treatment of immune disorders
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148571 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof
06/14/2012US20120148570 Methods and compositions for treating respiratory disease-challenged animals
06/14/2012US20120148569 Picrorhiza kurroa extract for prevention, elimination and treatment of infection diseases
06/14/2012US20120148568 Variant Immunoglobulins with Improved Manufacturability
06/14/2012US20120148567 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
06/14/2012US20120148566 Product and method for treatment of conditions associated with receptor-desensitization
06/14/2012US20120148565 Increasing lifespan by modulation of wwp-1 and ubc-18
06/14/2012US20120148564 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
06/14/2012US20120148529 Use of Inclusion Bodies as Therapeutic Agents
06/14/2012US20120148498 Compositions and Methods for the Systemic Treatment of Arthritis
06/14/2012US20120148495 Methods for treating nicotinic acetylcholine receptor associated diseases
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 1823